Ladenburg Thalmann Financial Services’s Stemline Therapeutics, Inc. STML Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$2K	Hold	180	–	–	﹤0.01%	5146
2019 Q3	$2K	Buy	180 +100	+125%	+$1.31K	﹤0.01%	5052
2019 Q2	$1K	Hold	80	–	–	﹤0.01%	5223
2019 Q1	$1K	Hold	80	–	–	﹤0.01%	5170
2018 Q4	$1K	Hold	80	–	–	﹤0.01%	5157
2018 Q3	$1K	Sell	80 -394	-83%	-$6.32K	﹤0.01%	5090
2018 Q2	$7K	Hold	474	–	–	﹤0.01%	4471
2018 Q1	$7K	Sell	474 -9,800	-95%	-$153K	﹤0.01%	4471
2017 Q4	$160K	Sell	10,274 -500	-5%	-$6.69K	﹤0.01%	2381
2017 Q3	$120K	Sell	10,774 -1,920	-15%	-$18.1K	﹤0.01%	2483
2017 Q2	$117K	Hold	12,694	–	–	﹤0.01%	2420
2017 Q1	$109K	Hold	12,694	–	–	﹤0.01%	2348
2016 Q4	$136K	Buy	12,694 +11,300	+811%	+$137K	﹤0.01%	2090
2016 Q3	$15K	Hold	1,394	–	–	﹤0.01%	3593
2016 Q2	$9K	Hold	1,394	–	–	﹤0.01%	3857
2016 Q1	$6K	Hold	1,394	–	–	﹤0.01%	4019
2015 Q4	$9K	Hold	1,394	–	–	﹤0.01%	3757
2015 Q3	$12K	Hold	1,394	–	–	﹤0.01%	3436
2015 Q2	$16K	Buy	1,394 +394	+39%	+$5.47K	﹤0.01%	3398
2015 Q1	$14K	Hold	1,000	–	–	﹤0.01%	3430
2014 Q4	$17K	Hold	1,000	–	–	﹤0.01%	3110
2014 Q3	$12K	Hold	1,000	–	–	﹤0.01%	3008
2014 Q2	$15K	Buy	+1,000	New	+$15.3K	﹤0.01%	2866

Other funds holding STML

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ladenburg Thalmann Financial Services's STML Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Stemline Therapeutics, Inc. (STML) position steady in Q4 2019 at 180 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5146.

Ladenburg Thalmann Financial Services first reported a position in STML in Q2 2014 and has held it in 23 quarters since. The position peaked at $160K in Q4 2017. 99 funds tracked by Wall St. Rank hold STML as of Q4 2019.

Ladenburg Thalmann Financial Services held 180 shares of Stemline Therapeutics, Inc. worth $2K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Stemline Therapeutics, Inc. share count unchanged in Q4 2019.
Stemline Therapeutics, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5146 holding.
Ladenburg Thalmann Financial Services first reported a position in Stemline Therapeutics, Inc. in Q2 2014 and has held it in 23 quarters since.
Ladenburg Thalmann Financial Services's Stemline Therapeutics, Inc. position peaked at $160K in Q4 2017.
99 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.